Oncology, one of Pierre Fabre main priorities
The company has recently reaffirmed oncology as one of its main priorities, focusing on targeted therapies, biotherapies and immuno-oncology. Its therapeutic areas include colorectal, breast, lung cancers, melanoma, pre-cancerous conditions such as actinic keratosis and EBV driven rare diseases.
Pierre Fabre commitment toward patients
What is TAVIE-Skin?
Patients diagnosed with advanced BRAFV600-mutant melanoma may seek information online or download digital health applications to better understand their disease and treatment. However, it is important that available digital solutions offer patients credible, reliable and easy-to-use tools to support them to better understand and manage their specific disease and treatment.
TAVIE Skin is the first targeted digital solution for patients with advanced BRAFV600-mutant melanoma who are treated with targeted therapy
Watch the video and download the brochure to learn more about TAVIE Skin.
How can TAVIE Skin help your patients?
A personalized and interactive patient companion along the treatment journey
Deliver the necessary information and educate patients on disease and medications
Advise patients on sustainable healthy behaviors
Keep track of medications to improve adherence
Assist patients in preparing their appointments and identifying side effects
To learn more on TAVIE Skin and how it can help support your patients, discover the dedicated website: